Plunkett Research Online: Diffusion Pharmaceuticals

DIFFUSION PHARMACEUTICALS (DFFN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

A clinical stage biotechnology company.....

Diffusion Pharmaceuticals
Ticker: DFFN
Exchange: NAS
Parent Company:
Year Established:
Fiscal Year Ends in

Phone: 434 220-0718
Fax: 434 220-0722
Address: 1317 Carlton Avenue
Suite 200
Charlottesville, VA 22902 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vaccines, Skin Replacement Products and Biologicals Manufacturing
Contacts Description

David Kalergis CEO/Chairman of the Board/Co-Founder/Director
William Hornung CFO/Chief Accounting Officer
See More
A clinical stage biotechnology company.....See More See More

Auditor: KPMG LLP
Legal Advisor: TroyGould PC
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: